Role of EDC Systems
During clinical trials, data quality and study efficiency are of the utmost importance. Electronic Data Capture (EDC) software helps sponsors collect trial data and manage processes including patient form design, medical coding, and source data verification. Prior to EDC, clinical trial data was documented on 3- part NCR paper, which was liable to various pain points. Data captured incorrectly at the source, forms delayed in transit, and inefficiency in back-and-forth communication were just a few challenges that sponsors faced. Nowadays, life sciences organizations typically capture data electronically at the source (“e-source”) or transcribe paper forms into an EDC system.
EDC Operational Models
Sponsors often consider whether to take an EDC in-house or partner with a CRO. While this decision depends on the unique Sponsor and study, here are general benefits of each operational model.
In-House EDC System
- Customization: Sponsors directly decide the EDC system setup and functionality; in turn, they are responsible for validation and maintenance
- Data Autonomy: because the Sponsor owns the system, access and control of data abides by your organization’s standards and your organization only
- Speed: In-house EDCs eliminate external communication bottlenecks; once trained, Sponsor personnel may pull study information and analyze without needing to consult outside parties
Outsourced EDC System
- Expertise: CROs have established experience, infrastructure, and resources to run efficient studies, allowing Sponsors to focus on more critical aspects of clinical operations
- Cost Efficiency: CROs offer competitive pricing through fixed contracts (however, post-production changes to the protocol can quickly result in change orders and cost escalation)
- Agility: CROs can quickly deploy EDC systems across multiple studies. ProPharma can work in a variety of systems depending on your study’s phase and therapeutic area
EDC User Roles
Sponsors, contract research organizations (CRO), and sites play critical roles in clinical data collection. Common EDC roles include:
- Study Builders
- System Administrators
- Data Managers
- Clinical Research Coordinates
- Clinical Research Administrations
- Study Investigators
- Medical Coding
- Inventory Control
- Biostatistics
A robust EDC platform supports them in the following day-to-day tasks
Sponsor/CRO
- Designing customized study forms (eCRF)
- Performing Validation and/or User Acceptance Testing, both at the system and study level
- Training sites on using the EDC for each specific study
- Overseeing studies to ensure compliance with protocols, Good Clinical Practices, and all applicable regulations
- Monitoring data collection for discrepancies
- Reviewing source documentation and case report forms
- Analyzing data metrics as requested by Sponsor
- Submitting queries to sites to resolve trial issues
Site
- Entering participant information, such as research data and patient’s background
- Reviewing and processing clinical trial data
Business Requirements
EDC solutions are not one-size-fits-all. Determine which features are nice-to-have, and which ones are critical for your organization. For example, if CTMS integration and no coding are requirements, confirm that potential vendors will support those needs.
News & Insights
December 19, 2024
WHO Issues Guidance on Antibiotic Pollution Control
WHO issues guidance to control antibiotic pollution from manufacturing, addressing environmental and global health impacts of antimicrobial resistance.
December 18, 2024
Nonclinical Drug Development: FDA Recommendations for Confirming an Ames Positive Finding
Explore FDA's recommendations on follow-up testing for Ames-positive drugs to support first-in-human clinical trials. Learn how to navigate FDA regulations and ensuring successful product development.
December 17, 2024
Navigating Market Access & Reimbursement Strategy for Medical Devices in Europe
Explore the importance of market access and reimbursement strategies for medical devices and in vitro diagnostics (IVDs) in Europe. Learn how early planning and the new European HTAR can enhance the...
News & Insights
October 21, 2024
ProPharma Appoints Brian Tuttle as Chief Financial Officer
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
October 9, 2024
ProPharma Receives 2024 CPHI Regulatory and Compliance Award
ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.
September 30, 2024
ProPharma Names Dawn Sherman Chief Executive Officer
Dawn Sherman rejoins ProPharma as CEO, bringing nearly 30 years of industry experience to lead the regulatory, clinical, and compliance services provider.
